AMOEBA (EPA:ALMIB) | WebDisclosure

Basculer en Français

8295	Companies
114863	Keywords
55304	Articles
62446	Press releases

Home
Companies
AMOEBA

BRIEF

published on 10/07/2024 at 17:50, 1 month 13 days ago

Amoéba Publishes its Half-Yearly Financial Report as of June 30, 2024

AMOEBA Investors Financial Report Biocontrol Cosmetic
BRIEF

published on 10/07/2024 at 17:50, 1 month 13 days ago

Amoéba Publie son Rapport Financier Semestriel au 30 Juin 2024

AMOEBA Biocontrôle Cosmétique Rapport Financier Investisseurs
PRESS RELEASE

published on 10/07/2024 at 17:45, 1 month 13 days ago

Amoéba: Publication of the half-year financial report at 30 June 2024
Amoéba announces the publication of its half-year financial report for 2024 and upcoming institutional investor event. Amoéba, a greentech company, provides natural microbiological solutions

AMOEBA Investor Event Half-year Financial Report GreenTech Microbiological Solutions
PRESS RELEASE

published on 10/07/2024 at 17:45, 1 month 13 days ago

Amoéba : Mise à disposition du rapport financier semestriel au 30 juin 2024
Amoéba, société greentech basée à Chassieu, publie son rapport financier semestriel au 30 juin 2024 et annonce un prochain séminaire Biotech & Santé. En savoir plus sur amoeba-nature.com

AMOEBA Biotech Rapport Financier GreenTech Séminaire
BRIEF

published on 10/03/2024 at 17:50, 1 month 17 days ago

Amoéba confirme son pivot stratégique au premier semestre 2024

Stratégie AMOEBA Biocontrôle Cosmétique GreenTech
BRIEF

published on 10/03/2024 at 17:50, 1 month 17 days ago

Amoéba confirms its strategic pivot in the first half of 2024

AMOEBA Strategy Biocontrol GreenTech Cosmetic
PRESS RELEASE

published on 10/03/2024 at 17:45, 1 month 17 days ago

Amoéba: the first half of 2024 confirms the strategic pivot towards an industrial and commercial company from 2025 onwards
Amoéba reports strategic shift to commercial focus & positive operating income growth in H1 2024. Financial outlook secured until mid-2025. Development plans for biocontrol & cosmetics segments

AMOEBA Financial Results Biocontrol Cosmetics Strategic Shift
PRESS RELEASE

published on 10/03/2024 at 17:45, 1 month 17 days ago

Amoéba : un premier semestre 2024 confirmant le pivot stratégique vers une entreprise industrielle et commerciale dès 2025
Amoéba annonce ses résultats pour le 1er semestre 2024 et son tournant stratégique vers une société commerciale. Amélioration du résultat opérationnel et visibilité financière jusqu'en 2025. Perspectives de développement biocontrôle et cosmétique

AMOEBA Développement Résultats Commercialisation Tournant Stratégique
BRIEF

published on 10/02/2024 at 17:50, 1 month 18 days ago

AMOEBA : Nombre total de droits de vote et d'actions au 30 septembre 2024

AMOEBA Capital Droits De Vote Actions Marchés Financiers
BRIEF

published on 10/02/2024 at 17:50, 1 month 18 days ago

AMOEBA: Total number of voting rights and shares as of September 30, 2024

AMOEBA Voting Rights Capital Actions Financial Markets

1 2 ... 8

Accesswire

Published on 11/21/2024 at 12:00, 1 hour 3 minutes ago

Alset AI Announces Full Repayment of $3.7 Million Secured Loan with Interest from Portfolio Company, Significantly Strengthening Balance Sheet
Published on 11/21/2024 at 12:00, 1 hour 3 minutes ago

Battery X Metals Commences Strategic Initiatives to Strengthen Balance Sheet
Published on 11/21/2024 at 11:30, 1 hour 33 minutes ago

FireFox Trenching Returns More High-Grade Gold at the Mustajärvi Gold Project in Lapland, Finland
Published on 11/21/2024 at 10:03, 3 hours ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 3 hours 3 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 12:35, 27 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 48 minutes ago

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 12:06, 56 minutes ago

IVU AG publishes Quarterly Report Q3-2024
Published on 11/21/2024 at 12:00, 1 hour 2 minutes ago

Holding(s) in Company
Published on 11/21/2024 at 11:30, 1 hour 33 minutes ago

APONTIS PHARMA AG: Condition of Minimum Acceptance in Zentiva’s Voluntary Public Purchase Offer Waived

Les Echos

Published on 11/21/2024 at 06:58, 6 hours 5 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 6 hours 5 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 6 hours 5 minutes ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 16 hours 55 minutes ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 17 hours 43 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE